 |
PDBsum entry 1shu
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Membrane protein
|
PDB id
|
|
|
|
1shu
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
101:6367-6372
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor.
|
|
D.B.Lacy,
D.J.Wigelsworth,
H.M.Scobie,
J.A.Young,
R.J.Collier.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Anthrax toxin is released from Bacillus anthracis as three monomeric proteins,
which assemble into toxic complexes at the surface of receptor-bearing host
cells. One of the proteins, protective antigen (PA), binds to receptors and
orchestrates the delivery of the other two (the lethal and edema factors) into
the cytosol. PA has been shown to bind to two cellular receptors: anthrax toxin
receptor/tumor endothelial marker 8 and capillary morphogenesis protein 2
(CMG2). Both are type 1 membrane proteins that include an approximately 200-aa
extracellular von Willebrand factor A (VWA) domain with a metal ion-dependent
adhesion site (MIDAS) motif. The anthrax toxin receptor/tumor endothelial marker
8 and CMG2 VWA domains share approximately 60% amino acid identity and bind PA
directly in a metal-dependent manner. Here, we report the crystal structure of
the CMG2 VWA domain, with and without its intramolecular disulfide bond, to 1.5
and 1.8 A, respectively. Both structures contain a carboxylate ligand-mimetic
bound at the MIDAS and appear as open conformations when compared with the VWA
domains from alpha-integrins. The CMG2 structures provide a template to begin
probing the high-affinity CMG2-PA interaction (200 pM) and may facilitate
understanding of toxin assembly/internalization and the development of new
anthrax treatments. The structural data also allow molecular interpretation of
known CMG2 VWA domain mutations linked to the genetic disorders, juvenile
hyaline fibromatosis, and infantile systemic hyalinosis.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Structure of the CMG2 VWA domain. A ribbon diagram
of the S38 structure indicates secondary structure elements.
Highlighted amino acid residues include the N- and C-terminal
cysteines (C39 and C218, respectively) that form a disulfide
bond (the sulfur atoms are depicted in yellow) and the conserved
amino acids of the MIDAS motif. The Mg2+ ion is shown as a large
blue sphere with two bound water molecules depicted as beige
spheres. The small red spheres correspond to oxygen atoms within
the MIDAS amino acids. The E194 residue from a neighboring CMG2
molecule (only E194 is shown in pink) contributes the sixth
coordinating residue at the MIDAS metal. The structures of S38
and R40 superimpose with an rms deviation of 0.7 Å2. They
differ primarily in the orientation of the 6 C-terminal helix.
This helix and its preceding loop in the R40 structure are
depicted in blue. This image and Fig. 3 were generated by the
program MOLSCRIPT (47) and rendered in RASTER3D (48).
|
 |
Figure 3.
Fig. 3. The CMG2 VWA domain is in an open conformation. (a)
The backbone structure of the CMG2 VWA domain (light green) was
superimposed onto the aligned structures of the M
integrin I domains in their open (dark green, PDB ID code 1IDO
[PDB]
) and closed (blue, PDB ID code 1JLM [PDB]
) conformations (23, 26). The hydrophobic pockets I and II are
indicated by gray ovals and the Mg2+ ion for CMG2 is depicted as
a blue sphere. (b) The closed conformation of M with
Phe-302 buried in hydrophobic pocket I and Ile-316 buried in
hydrophobic pocket II. (c) The open conformation of M shows
a shift in the C-terminal helix from its position in b such that
Phe-302 becomes solvent-exposed, and hydrophobic pocket II is
now occupied by Leu-312. The positions of Phe-275 and Gly-243
have also shifted. (d) The structure of the CMG2 VWA domain is
similar to that of c and is therefore an open conformation. It
is hypothesized that the presence of Ile-213 bound in
hydrophobic pocket II and the absence of a downstream
hydrophobic residue equivalent to M Ile-316 might help
stabilize the open conformation. Residues that, when mutated,
result in ISH and JHF disease (Leu-45, Gly-105, Ile-189, and
Cys-218) are depicted in yellow. (e) In the closed structure of
M,
the Mn2+ ion (blue sphere) is coordinated by three waters, two
MIDAS serines, and an aspartic acid. The bond to the MIDAS
threonine has been broken.(f) In the open structure of M, the
Mg2+ ion is coordinated directly by two serines, two waters
(medium red spheres), a threonine, and a glutamate from a
neighboring monomer. (g) The coordination of the MIDAS metal in
the CMG2 VWA domain structure is identical to the coordination
observed for the open conformation of M shown in f.
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.B.Hoppa,
B.Lana,
W.Margas,
A.C.Dolphin,
and
T.A.Ryan
(2012).
α2δ expression sets presynaptic calcium channel abundance and release probability.
|
| |
Nature,
486,
122-125.
|
 |
|
|
|
|
 |
J.Deuquet,
E.Lausch,
N.Guex,
L.Abrami,
S.Salvi,
A.Lakkaraju,
M.C.Ramirez,
J.A.Martignetti,
D.Rokicki,
L.Bonafe,
A.Superti-Furga,
and
F.G.van der Goot
(2011).
Hyaline Fibromatosis Syndrome inducing mutations in the ectodomain of anthrax toxin receptor 2 can be rescued by proteasome inhibitors.
|
| |
EMBO Mol Med,
3,
208-221.
|
 |
|
|
|
|
 |
L.M.Cryan,
and
M.S.Rogers
(2011).
Targeting the anthrax receptors, TEM-8 and CMG-2, for anti-angiogenic therapy.
|
| |
Front Biosci,
16,
1574-1588.
|
 |
|
|
|
|
 |
A.F.Kintzer,
H.J.Sterling,
I.I.Tang,
E.R.Williams,
and
B.A.Krantz
(2010).
Anthrax toxin receptor drives protective antigen oligomerization and stabilizes the heptameric and octameric oligomer by a similar mechanism.
|
| |
PLoS One,
5,
e13888.
|
 |
|
|
|
|
 |
D.Herrmann,
A.Ferrer-Vaquer,
C.Lahsnig,
N.Firnberg,
A.Leibbrandt,
and
A.Neubüser
(2010).
Expression and regulation of ANTXR1 in the chick embryo.
|
| |
Dev Dyn,
239,
680-687.
|
 |
|
|
|
|
 |
J.Sun,
and
R.J.Collier
(2010).
Disulfide bonds in the ectodomain of anthrax toxin receptor 2 are required for the receptor-bound protective-antigen pore to function.
|
| |
PLoS One,
5,
e10553.
|
 |
|
|
|
|
 |
M.Martchenko,
S.Y.Jeong,
and
S.N.Cohen
(2010).
Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin.
|
| |
Proc Natl Acad Sci U S A,
107,
15583-15588.
|
 |
|
|
|
|
 |
S.Fu,
X.Tong,
C.Cai,
Y.Zhao,
Y.Wu,
Y.Li,
J.Xu,
X.C.Zhang,
L.Xu,
W.Chen,
and
Z.Rao
(2010).
The structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin.
|
| |
PLoS One,
5,
e11203.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.S.Williams,
S.Lovell,
A.Anbanandam,
R.El-Chami,
and
J.G.Bann
(2009).
Domain 4 of the anthrax protective antigen maintains structure and binding to the host receptor CMG2 at low pH.
|
| |
Protein Sci,
18,
2277-2286.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.D.Kelly-Cirino,
and
N.J.Mantis
(2009).
Neutralizing monoclonal antibodies directed against defined linear epitopes on domain 4 of anthrax protective antigen.
|
| |
Infect Immun,
77,
4859-4867.
|
 |
|
|
|
|
 |
G.van der Goot,
and
J.A.Young
(2009).
Receptors of anthrax toxin and cell entry.
|
| |
Mol Aspects Med,
30,
406-412.
|
 |
|
|
|
|
 |
J.Deuquet,
L.Abrami,
A.Difeo,
M.C.Ramirez,
J.A.Martignetti,
and
F.G.van der Goot
(2009).
Systemic hyalinosis mutations in the CMG2 ectodomain leading to loss of function through retention in the endoplasmic reticulum.
|
| |
Hum Mutat,
30,
583-589.
|
 |
|
|
|
|
 |
J.N.Tournier,
S.Rossi Paccani,
A.Quesnel-Hellmann,
and
C.T.Baldari
(2009).
Anthrax toxins: a weapon to systematically dismantle the host immune defenses.
|
| |
Mol Aspects Med,
30,
456-466.
|
 |
|
|
|
|
 |
K.Liu,
E.W.Wong,
S.E.Schutzer,
N.D.Connell,
A.Upadhyay,
M.Bryan,
and
P.Rameshwar
(2009).
Non-canonical effects of anthrax toxins on haematopoiesis: implications for vaccine development.
|
| |
J Cell Mol Med,
13,
1907-1919.
|
 |
|
|
|
|
 |
K.Tan,
M.Duquette,
A.Joachimiak,
and
J.Lawler
(2009).
The crystal structure of the signature domain of cartilage oligomeric matrix protein: implications for collagen, glycosaminoglycan and integrin binding.
|
| |
FASEB J,
23,
2490-2501.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Y.Go,
E.M.Chow,
and
J.Mogridge
(2009).
The cytoplasmic domain of anthrax toxin receptor 1 affects binding of the protective antigen.
|
| |
Infect Immun,
77,
52-59.
|
 |
|
|
|
|
 |
R.J.Collier
(2009).
Membrane translocation by anthrax toxin.
|
| |
Mol Aspects Med,
30,
413-422.
|
 |
|
|
|
|
 |
D.J.Manayani,
D.Thomas,
K.A.Dryden,
V.Reddy,
M.E.Siladi,
J.M.Marlett,
G.J.Rainey,
M.E.Pique,
H.M.Scobie,
M.Yeager,
J.A.Young,
M.Manchester,
and
A.Schneemann
(2007).
A viral nanoparticle with dual function as an anthrax antitoxin and vaccine.
|
| |
PLoS Pathog,
3,
1422-1431.
|
 |
|
|
|
|
 |
H.M.Scobie,
J.M.Marlett,
G.J.Rainey,
D.B.Lacy,
R.J.Collier,
and
J.A.Young
(2007).
Anthrax toxin receptor 2 determinants that dictate the pH threshold of toxin pore formation.
|
| |
PLoS ONE,
2,
e329.
|
 |
|
|
|
|
 |
J.A.Young,
and
R.J.Collier
(2007).
Anthrax toxin: receptor binding, internalization, pore formation, and translocation.
|
| |
Annu Rev Biochem,
76,
243-265.
|
 |
|
|
|
|
 |
K.H.Chen,
S.Liu,
L.A.Bankston,
R.C.Liddington,
and
S.H.Leppla
(2007).
Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells.
|
| |
J Biol Chem,
282,
9834-9845.
|
 |
|
|
|
|
 |
K.Sherer,
Y.Li,
X.Cui,
and
P.Q.Eichacker
(2007).
Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapy.
|
| |
Am J Respir Crit Care Med,
175,
211-221.
|
 |
|
|
|
|
 |
Q.Xu,
E.D.Hesek,
and
M.Zeng
(2007).
Transcriptional stimulation of anthrax toxin receptors by anthrax edema toxin and Bacillus anthracis Sterne spore.
|
| |
Microb Pathog,
43,
37-45.
|
 |
|
|
|
|
 |
S.Liu,
H.J.Leung,
and
S.H.Leppla
(2007).
Characterization of the interaction between anthrax toxin and its cellular receptors.
|
| |
Cell Microbiol,
9,
977-987.
|
 |
|
|
|
|
 |
Y.Li,
K.Sherer,
X.Cui,
and
P.Q.Eichacker
(2007).
New insights into the pathogenesis and treatment of anthrax toxin-induced shock.
|
| |
Expert Opin Biol Ther,
7,
843-854.
|
 |
|
|
|
|
 |
H.M.Scobie,
D.J.Wigelsworth,
J.M.Marlett,
D.Thomas,
G.J.Rainey,
D.B.Lacy,
M.Manchester,
R.J.Collier,
and
J.A.Young
(2006).
Anthrax toxin receptor 2-dependent lethal toxin killing in vivo.
|
| |
PLoS Pathog,
2,
e111.
|
 |
|
|
|
|
 |
I.I.Salles,
D.E.Voth,
S.C.Ward,
K.M.Averette,
R.K.Tweten,
K.A.Bradley,
and
J.D.Ballard
(2006).
Cytotoxic activity of Bacillus anthracis protective antigen observed in a macrophage cell line overexpressing ANTXR1.
|
| |
Cell Microbiol,
8,
1272-1281.
|
 |
|
|
|
|
 |
J.W.Peterson,
J.E.Comer,
D.M.Noffsinger,
A.Wenglikowski,
K.G.Walberg,
B.M.Chatuev,
A.K.Chopra,
L.R.Stanberry,
A.S.Kang,
W.W.Scholz,
and
J.Sircar
(2006).
Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax.
|
| |
Infect Immun,
74,
1016-1024.
|
 |
|
|
|
|
 |
M.Gao,
and
K.Schulten
(2006).
Onset of anthrax toxin pore formation.
|
| |
Biophys J,
90,
3267-3279.
|
 |
|
|
|
|
 |
R.A.Melnyk,
and
R.J.Collier
(2006).
A loop network within the anthrax toxin pore positions the phenylalanine clamp in an active conformation.
|
| |
Proc Natl Acad Sci U S A,
103,
9802-9807.
|
 |
|
|
|
|
 |
S.Basha,
P.Rai,
V.Poon,
A.Saraph,
K.Gujraty,
M.Y.Go,
S.Sadacharan,
M.Frost,
J.Mogridge,
and
R.S.Kane
(2006).
Polyvalent inhibitors of anthrax toxin that target host receptors.
|
| |
Proc Natl Acad Sci U S A,
103,
13509-13513.
|
 |
|
|
|
|
 |
T.A.Springer
(2006).
Complement and the multifaceted functions of VWA and integrin I domains.
|
| |
Structure,
14,
1611-1616.
|
 |
|
|
|
|
 |
C.Cantí,
M.Nieto-Rostro,
I.Foucault,
F.Heblich,
J.Wratten,
M.W.Richards,
J.Hendrich,
L.Douglas,
K.M.Page,
A.Davies,
and
A.C.Dolphin
(2005).
The metal-ion-dependent adhesion site in the Von Willebrand factor-A domain of alpha2delta subunits is key to trafficking voltage-gated Ca2+ channels.
|
| |
Proc Natl Acad Sci U S A,
102,
11230-11235.
|
 |
|
|
|
|
 |
G.J.Rainey,
D.J.Wigelsworth,
P.L.Ryan,
H.M.Scobie,
R.J.Collier,
and
J.A.Young
(2005).
Receptor-specific requirements for anthrax toxin delivery into cells.
|
| |
Proc Natl Acad Sci U S A,
102,
13278-13283.
|
 |
|
|
|
|
 |
H.M.Scobie,
and
J.A.Young
(2005).
Interactions between anthrax toxin receptors and protective antigen.
|
| |
Curr Opin Microbiol,
8,
106-112.
|
 |
|
|
|
|
 |
J.Liu,
N.Jambunathan,
and
T.W.McNellis
(2005).
Transgenic expression of the von Willebrand A domain of the BONZAI 1/COPINE 1 protein triggers a lesion-mimic phenotype in Arabidopsis.
|
| |
Planta,
221,
85-94.
|
 |
|
|
|
|
 |
L.Abrami,
N.Reig,
and
F.G.van der Goot
(2005).
Anthrax toxin: the long and winding road that leads to the kill.
|
| |
Trends Microbiol,
13,
72-78.
|
 |
|
|
|
|
 |
M.M.Numa,
L.V.Lee,
C.C.Hsu,
K.E.Bower,
and
C.H.Wong
(2005).
Identification of novel anthrax lethal factor inhibitors generated by combinatorial Pictet-Spengler reaction followed by screening in situ.
|
| |
Chembiochem,
6,
1002-1006.
|
 |
|
|
|
|
 |
S.S.Kocer,
S.G.Walker,
B.Zerler,
L.M.Golub,
and
S.R.Simon
(2005).
Metalloproteinase inhibitors, nonantimicrobial chemically modified tetracyclines, and ilomastat block Bacillus anthracis lethal factor activity in viable cells.
|
| |
Infect Immun,
73,
7548-7557.
|
 |
|
|
|
|
 |
D.B.Lacy,
D.J.Wigelsworth,
R.A.Melnyk,
S.C.Harrison,
and
R.J.Collier
(2004).
Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation.
|
| |
Proc Natl Acad Sci U S A,
101,
13147-13151.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.Santelli,
L.A.Bankston,
S.H.Leppla,
and
R.C.Liddington
(2004).
Crystal structure of a complex between anthrax toxin and its host cell receptor.
|
| |
Nature,
430,
905-908.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.G.Bann,
and
S.J.Hultgren
(2004).
Structural biology: anthrax hijacks host receptor.
|
| |
Nature,
430,
843-844.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |